Home
ETON
ETON News

Latest Eton Pharmaceuticals Inc. (ETON) News on October 30, 2025

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

GlobeNewswire

7 days ago

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

MT Newswires

4 months ago

Eton Pharmaceuticals to Be Added to Russell 2000 and 3000 Indexes

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

GlobeNewswire

4 months ago

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

Insiders Back These 3 High Growth Companies

Simply Wall St.

4 months ago

Insiders Back These 3 High Growth Companies

MT Newswires

4 months ago

Eton Pharmaceuticals Insider Sold Shares Worth $504,318, According to a Recent SEC Filing

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 06/06/2025

Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why

Zacks

5 months ago

Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why

Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why

Zacks

5 months ago

Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why

MT Newswires

5 months ago

Sector Update: Health Care Stocks Edge Higher Pre-Bell Thursday

MT Newswires

5 months ago

Sector Update: Health Care

FDA approves Eton’s application for hydrocortisone oral solution

Pharmaceutical Technology

5 months ago

FDA approves Eton’s application for hydrocortisone oral solution

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency

Insider Monkey

5 months ago

Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency

MT Newswires

5 months ago

Eton Pharmaceuticals' Khindivi Gets FDA Approval for Pediatric Adrenocortical Insufficiency Treatment

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

GlobeNewswire

5 months ago

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week

Simply Wall St.

5 months ago

individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

GlobeNewswire

6 months ago

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...

GuruFocus.com

6 months ago

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

Zacks

6 months ago

Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates

MT Newswires

6 months ago

Eton Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

GlobeNewswire

6 months ago

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

6 months ago

Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect

Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline

Zacks

6 months ago

Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

GlobeNewswire

6 months ago

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

Zacks

6 months ago

Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release

MT Newswires

6 months ago

Eton Pharmaceuticals Submits NDA to FDA for ET-600 to Treat Central Diabetes Insipidus

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

GlobeNewswire

6 months ago

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

Simply Wall St.

6 months ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

MT Newswires

7 months ago

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

GlobeNewswire

7 months ago

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect

GuruFocus.com

7 months ago

Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

7 months ago

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Zacks

7 months ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

GlobeNewswire

7 months ago

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

MT Newswires

8 months ago

Eton's Diabetes Drug Candidate Passes Bioequivalence Study

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

GlobeNewswire

8 months ago

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Zacks

8 months ago

Is 89BIO (ETNB) Stock Outpacing Its Medical Peers This Year?

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

GlobeNewswire

8 months ago

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

MT Newswires

8 months ago

Eton Pharmaceuticals Launches Galzin Capsules for Wilson Disease Treatment

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

GlobeNewswire

8 months ago

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?

Zacks

8 months ago

Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?

Eton secures US patent for diabetes insipidus treatment

Pharmaceutical Technology

9 months ago

Eton secures US patent for diabetes insipidus treatment

MT Newswires

9 months ago

Eton Pharmaceuticals Says US Patent Granted for ET-600 Formulation

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

GlobeNewswire

9 months ago

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

MT Newswires

9 months ago

Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

GlobeNewswire

9 months ago

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

New Strong Buy Stocks for January 28th

Zacks

9 months ago

New Strong Buy Stocks for January 28th

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum

TipRanks

9 months ago

Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Zacks

9 months ago

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?

Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now

Insider Monkey

9 months ago

Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now

MT Newswires

10 months ago

B. Riley Initiates Eton Pharmaceuticals With Buy Rating, $21 Price Target

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain

Simply Wall St.

10 months ago

Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain

MT Newswires

10 months ago

Eton Pharmaceuticals Acquires Galzin to Expand Rare Disease Treatment Offerings

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

GlobeNewswire

10 months ago

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

MT Newswires

10 months ago

Eton Pharmaceuticals Acquires Increlex From Ipsen; Shares Rise

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

GlobeNewswire

10 months ago

Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

GlobeNewswire

10 months ago

Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions

Simply Wall St.

a year ago

Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) top owners are retail investors with 58% stake, while 26% is held by institutions

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

GlobeNewswire

a year ago

Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer

Eton acquires US rights to neonatal diabetes treatment from AMMTeK

Pharmaceutical Technology

a year ago

Eton acquires US rights to neonatal diabetes treatment from AMMTeK

Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK

TipRanks

a year ago

Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK

MT Newswires

a year ago

Eton Pharmaceuticals Acquires US Rights to Neonatal Diabetes Drug Amglidia

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

GlobeNewswire

a year ago

Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)

Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Eton Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q3 2024 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

GuruFocus.com

a year ago

Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

GlobeNewswire

a year ago

Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results

What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings

GuruFocus.com

a year ago

What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

a year ago

Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

GlobeNewswire

a year ago

Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum

TipRanks

a year ago

Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum

Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.

GuruFocus.com

a year ago

Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.

ACCESSWIRE

a year ago

SWK Holdings Provides Portfolio Update

Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long

Simply Wall St.

a year ago

Analysts Expect Breakeven For Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Before Long

Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares

GuruFocus.com

a year ago

Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares

MT Newswires

a year ago

Eton Pharmaceuticals to Acquire Increlex From Ipsen

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

GlobeNewswire

a year ago

Eton Pharmaceuticals, Inc to Acquire Increlex® (mecasermin injection) from Ipsen

GuruFocus.com

a year ago

Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

a year ago

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a year ago

Eton Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

GlobeNewswire

a year ago

Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results

Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago

Simply Wall St.

a year ago

Shareholders in Eton Pharmaceuticals (NASDAQ:ETON) are in the red if they invested five years ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

GlobeNewswire

a year ago

Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

ACCESSWIRE

a year ago

SWK Holdings Highlights Recent Achievements and Provides Portfolio Update

MT Newswires

a year ago

Eton Pharmaceuticals Shares Surge After FDA Accepts ET-400 New Drug Application For Review

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

a year ago

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Simply Wall St.

a year ago

Are Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?

Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations

Simply Wall St.

a year ago

Eton Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations

Thomson Reuters StreetEvents

a year ago

Q1 2024 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

GlobeNewswire

a year ago

Eton Pharmaceuticals Reports First Quarter 2024 Financial Results

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even

Simply Wall St.

a year ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

GlobeNewswire

a year ago

Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference

MT Newswires

2 years ago

Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

GlobeNewswire

2 years ago

Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

GlobeNewswire

2 years ago

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

GlobeNewswire

2 years ago

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

2 years ago

Q4 2023 Eton Pharmaceuticals Inc Earnings Call

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

GuruFocus.com

2 years ago

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Zacks

2 years ago

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates

Share on Social Networks: